ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.2225A>G (p.Asn742Ser)

dbSNP: rs1060499618
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000780978 SCV000918701 uncertain significance not specified 2018-03-07 criteria provided, single submitter clinical testing Variant summary: BRCA1 c.2225A>G (p.Asn742Ser) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 245910 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, the c.2225A>G variant has not been reported in the literature in individuals affected with Hereditary Breast and Ovarian Cancer and no experimental evidence demonstrating an impact on protein function has been reported. One co-occurrence with another pathogenic BRCA1 variant (c.5030_5033delCTAA (p.Thr1677fsX2)) has been found in an internal sample, providing supporting evidence for a benign role. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS - possibly benign.
University of Washington Department of Laboratory Medicine, University of Washington RCV003157511 SCV003847838 likely benign Hereditary cancer-predisposing syndrome 2023-03-23 criteria provided, single submitter curation Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673).
Eone-Diagnomics Genome Center RCV000460372 SCV000536940 uncertain significance Breast-ovarian cancer, familial, susceptibility to, 1 2016-11-04 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.